Celanese Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
Celanese Stock Forecast and Price Target
Celanese's stock price reaches the average target of $160.00 by 2025 as expected recently by eighteen notable experts, there would be a potential upside of approximately 3.48% from the last closing price in April, 2024. This possible increase is based on a high estimate of $199.00 and a low estimate of $120.00. If you're looking for Celanese (CE) stock information, you might also want to check out Alto Ingredients (NasdaqCM:ALTO).
3.48% Upside
Celanese Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Celanese's Price has fallen from $83.89 to $0.00 – a 100.00% decrease. In the next year, analysts predict that Fair Value will jump to $182.16 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GOOGL Stock Forecast | Alphabet | Outperform |
14
|
$156.01 | Buy/Sell | $163.84 | 7.48% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$262.75 | Buy/Sell | $303.65 | 20.74% |
| HON Stock Forecast | Honeywell International Inc | Outperform |
12
|
$191.08 | Buy/Sell | $219.12 | 16.44% |
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$393.48 | Buy/Sell | $457.59 | 14.36% |
| REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$893.99 | Buy/Sell | $961.26 | 17.45% |
Celanese Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Celanese's Revenue has grown, moving from $5.66B to $10.94B – an increase of 93.46%. According to 2 prominent analysts, Celanese's Revenue will fall by 15.43% in the next year, reaching $9.25B. Looking ahead to seven years, experts forecast that Revenue will grow by 22.36%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SHW Stock Forecast | Sherwin Williams | Outperform |
15
|
$309.38 | Buy/Sell | $317.38 | 9.81% |
| PH Stock Forecast | Parker-Hannifin Corp | Outperform |
10
|
$538.09 | Buy/Sell | $548.76 | 10.58% |
| 2010 Stock Forecast | Saudi Basic Industries | Outperform |
10
|
﷼80.90 | Buy/Sell | ﷼96.26 | 11.99% |
.jpg)
Celanese Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Celanese's Dividend per Share has seen an increase, rising from $2.48 to $2.74. This represents a growth of 10.48%. Analysts predict that Celanese's Dividend per Share will increase in the upcoming year, reaching $3.15. This would represent an increase of 14.96%. Over the next seven years, experts predict that Celanese's Dividend per Share will grow at a rate of 3.65%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAS Stock Forecast | BASF | Outperform |
12
|
51.07€ | Buy/Sell | 49.50€ | 9.65% |
| DOW Stock Forecast | Dow | Hold |
2
|
$56.49 | Buy/Sell | $57.75 | 6.21% |
| PPG Stock Forecast | PPG Industries | Outperform |
13
|
$135.11 | Buy/Sell | $159.04 | 18.42% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DSFIR Stock Forecast | DSM-Firmenich | Outperform |
18
|
102.75€ | Buy/Sell | 114.60€ | 16.79% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$190.52 | Buy/Sell | $299.62 | 53.26% |
| 8053 Stock Forecast | Sumitomo | Hold |
14
|
¥3.34k | Buy/Sell | ¥3.25k | 0.63% |
Celanese EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, EBITDA for Celanese has grown by 62.50%, going from $1.09B to $1.77B. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach $2.44B – an increase of 37.94%. Over the next seven years, experts anticipate that EBITDA growth for Celanese will be 101.90%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$236.93 | Buy/Sell | $284.08 | 25.35% |
| 1COV Stock Forecast | Covestro | Outperform |
18
|
49.95€ | Buy/Sell | 52.80€ | 7.11% |
| 3407 Stock Forecast | Asahi Kasei | Hold |
16
|
¥1.05k | Buy/Sell | ¥1.07k | -1.72% |
Celanese EBIT Forecast for 2023 - 2025 - 2030
Celanese's EBIT has grown in the last three years, jumping from $734.00M to $1.08B – an increase of 47.28%. In the next year, analysts predict that EBIT will reach $1.97B – an increase of 82.33%. For the next seven years, the forecast is for EBIT to grow by 134.31%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CRDA Stock Forecast | Croda International Plc | Outperform |
18
|
£48.49 | Buy/Sell | £65.12 | 5.18% |
| 4188 Stock Forecast | Mitsubishi Chemical Group | Hold |
14
|
¥916.10 | Buy/Sell | ¥948.18 | 4.79% |
| 3402 Stock Forecast | Toray Industries | Outperform |
18
|
¥693.90 | Buy/Sell | ¥891.82 | 34.03% |
Celanese EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Celanese's EPS has fallen from $7.64 to $0.00 – a 100.00% decrease. In the next year, analysts predict that EPS will jump to $16.59 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ICL Stock Forecast | ICL Group Ltd | Hold |
16
|
₪17.68 | Buy/Sell | ₪5.49 | -69.97% |
| 2310 Stock Forecast | Sahara International Petrochem... | Outperform |
18
|
﷼32.30 | Buy/Sell | ﷼40.73 | 20.74% |
| NEU Stock Forecast | NewMarket | Hold |
18
|
$583.38 | Buy/Sell | $450.00 | 11.59% |
.jpg)